Amiodarone

Hospital Medicine

Volumn 58, Issue 7, 1997, Pages 329-332

  Swanton, Howard ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CHEMICALLY INDUCED DISORDER; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LUNG; METABOLISM; MORTALITY; PHOTOSENSITIVITY DISORDER; REVIEW;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; LUNG; PHOTOSENSITIVITY DISORDERS; TACHYCARDIA, VENTRICULAR;

EID: 0031242021     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cairns JA, Connolly SJ, Roberts R et al (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349: 675-82
2. Doval HC, Nul DR, Perrone SV et al (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficienca Cardiaca en Argentina (GESICA). Lancet 344: 493-8
3. Gleadhill IC, Wise RA, Schonfeld SA et al (1989) Serial lung function testing in patients treated with amiodarone: a prospective study. Am J Med 86: 4-10
4. Holt D, Tucker GT, Jackson PR et al (1983) Amiodarone pharmacokinetics. Am Heart J 106: 840-7
5. Jessurun GAJ, Crijns HJGM (1997) Amiodarone pulmonary toxicity. Br Med J 314: 619-20
6. Julian DG, Camm AT, Frangin G et al (1997) Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: (EMIAT). Lancet 349: 667-74
7. Kowey PR, Marinchak RA, Rials SJ et al (1997) Intravenous amiodarone. J Am Coll Cardiol 29: 1190-8
8. Kumar A, Borsey DQ (1994) Amiodarone-related thyroid dysfunction. Br J Hosp Med 52: 283-8
9. McKenna WJ, Oakley CM, Krikler DM et al (1985) Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia, Br Heart J 53: 412-16
10. Nul DR, Doval HC, Grancelli HO et al (1997) Heart rate is a marker of amiodarone reduction in severe heart failure. J Am Coll Cardiol 29: 1199-205
11. Oates JA, Wood AJJ (1987) Amiodarone. N Engl J Med 316: 455-66
12. Reichert LJM, de Rooy HAM (1989) Treatment of amiodarone induced hyperthyroidism with potassium permanganate and methimazole during amiodarone treatment. Br Med J 298: 1547-8
13. Rotmensch HH, Liron M, Tupilski M et al (1980) Possible association of pneumonitis with amiodarone therapy. Am Heart J 100: 412-13
14. Singh SN, Fletcher RD, Fisher SG et al (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333: 77-122